TyG index and coronary flow reserve may help assess CV risk in women with gestational diabetes
Turkey: A new article published in Medicina has revealed a significant association between the triglyceride glucose (TyG) index and coronary flow reserve (CFR) in patients with gestational diabetes mellitus (GDM).
The findings suggest the potential role of the TyG index and coronary flow reserve in assessing cardiovascular (CV) risk.
Gestational diabetes is a prevalent metabolic disorder, affecting approximately 7% of pregnancies worldwide, making it one of the most prevalent medical conditions during gestation. It is characterized by glucose tolerance during pregnancy. The TyG index, a marker of insulin resistance, and CFR, a measure of coronary microvascular function, are emerging as potential indicators of CV risk. '
Serhan Ozyildirim, Institute of Cardiology, Department of Cardiology, Istanbul University-Cerrahpasa, Istanbul, Turkey, and colleagues aimed to explore the potential association between CFR and the TyG index in patients with gestational diabetes in a cross-sectional study.
The study comprised 87 GDM patients (GDM group) and 36 healthy controls (control group). The participants underwent blood tests, clinical assessments, and echocardiographic evaluations. CFR was measured using Doppler echocardiography during rest and hyperemia induced by dipyridamole. The TyG index was calculated as ln(triglycerides × fasting glucose/2).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.